Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Jazz Pharmaceuticals and MD Anderson Announce Five-Year Collaboration to Evaluate Zanidatamab in HER2-Expressing Cancers
Wednesday, November 08, 2023Jazz Pharmaceuticals plc and The University of Texas MD Anderson Cancer Center today announced a fiveyear strategic research collaboration agreement to evaluate zanidatamab
MannKind Announces Completion of Enrollment in U.S. Phase 4 Inhale-3 Clinical Trial in Patients Living With Type 1 Diabetes
Tuesday, November 07, 2023MannKind Corporation a company focused on the development and commercialization of inhaled therapeutic products and devices for patients with endocrine and orphan lung diseases
Aura Biosciences Receives FDA SPA for Bel-sar Phase 3 Trial in Choroidal Melanoma
Tuesday, November 07, 2023Aura Biosciences Inc a clinicalstage biotechnology company developing a novel class of viruslike drug conjugate therapies for multiple oncology indications today announced it has received agreement
Revive Therapeutics Signs Exclusive Deal with Lawson Health Research Institute for Long COVID Rapid Test
Tuesday, November 07, 2023Revive Therapeutics Ltd a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders newlyformed subsidiary Revive Diagnostics Inc
MaaT Pharma Announces First Patient Dosed in Phase 2b Randomized Clinical Trial Evaluating MaaT033 in Patients Receiving Allo-HSCT
Monday, November 06, 2023MaaT Pharma a clinicalstage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM MET dedicated to enhancing survival for patients with cancer
Mirati Therapeutics' KRAZATI (adagrasib) Approved by MHRA for Advanced NSCLC with KRASG12C Mutation
Saturday, November 04, 2023Mirati Therapeutics Inc a commercial stage biotechnology company today announced the United Kingdoms Medicines and Healthcare Products Regulatory Agency granted conditional marketing authorization approval for KRAZATI
Fortrea Completes Expansion of Clinical Pharmacology Solutions With Targeted Investment in Four Clinical Research Sites in US and UK
Saturday, November 04, 2023Fortrea a world leader in commissioned research today announced that after years of hard work it has completed clinical pharmacology solutions and manufacturing capabilities The extension is now fully available to customers
Bioinvent Presents Positive Data at SITC From Clinical Phase 1/2a Trial of BI-1808 as Single Agent
Saturday, November 04, 2023BioInvent International AB a biotech company focused on the discovery and development of novel and firstinclass immunemodulatory antibodies for cancer immunotherapy today presents the latest data from a Phase a trial
Updated Version of Novavax's COVID-19 Vaccine Now Approved in the EU
Friday, November 03, 2023Novavax Inc a global company advancing proteinbased vaccines with its MatrixM adjuvant today announced that the Commission European Union has approved the dispersion of Nuvaxovid
Endo Launches Colchicine Capsules, Generic Version of MITIGARE®
Friday, November 03, 2023Endo International plc announced today that one of its operating companies Par Pharmaceutical Inc has begun shipping colchicine mg capsules a generic version of Hikmas MITIGARE
